To ensure our programs deliver the best possible solutions, The Foundation maintains a portfolio of high quality, high impact research and innovation. These investments strengthen the evidence base, improve program performance, further global thinking on ending avoidable blindness and support our advocacy and policy efforts.

Our research is complemented by rigorous program monitoring and evaluation, which build our organisational capacity and strengthen the performance of our programs ensuring we continue to deliver what works for individuals and communities in need.

Our commitment to innovation, and to improving and evaluating our work sets The Foundation apart:
  • We believe in delivering the best possible solutions, backed by evidence.
  • We remain willing to trial new approaches and are committed to continuous quality improvement and excellence.
  • We believe that sharing our insights, facilitating knowledge exchange with our partners and scaling-up innovative solutions is key to driving large-scale systemic change.
Our Research and Evaluations report summarises The Foundation’s research and evaluation publications in 2018. Read on for a snapshot and to download the full report.



What are the key concepts discussed?

To share our insights from 2018, we’ve summarised the abstracts and key details of articles and reports from evaluations and research publications released throughout the year.

Each article is categorised according to our key disease priorities: It also covers other cross-cutting themes like health systems strengthening and equity.

The report features abstracts of 27 peer-reviewed articles, summaries of 13 research and evaluation reports, and one strategic eval­uation report. If you have any questions about any of the research or evaluation work we support, you can always contact our Development Effectiveness team via [email protected] 

Each piece of research and evaluation helps improve The Foundation’s understanding of key eye health issues, and build the evidence base we use to improve our programs and to advocate to governments and other decision makers to invest in eliminating avoidable blindness and vision impairment.